A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yogish Kudva, MBBS
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lawson Health Research Institute
London, Ontario, Canada
- Mcgill University
Montreal, Quebec, Canada
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Rocky Mountain Clinical Research
Idaho Falls, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- Baltimore Va Medical Center
Baltimore, Maryland, United States
- Boston Medical Center Corporation
Boston, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Icahn School of Medicine at Mt. Sinai
New York, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Uhh Cleveland Medical Center
Cleveland, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Texas Diabetes and Endocrinology, P.A.
Austin, Texas, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Diabetes & Endocrine Treatment Specialists
Sandy City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
- Rainier Clinical Research Center
Renton, Washington, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2023
- Primary completion
- 24 Sept 2024
- Completion
- 24 Sept 2024
- Last update posted
- 22 May 2026
- Registered enrollment
- 319
- Registry id
- NCT05785832
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.